157 related articles for article (PubMed ID: 3307167)
1. [Determination of non-organ specific autoantibodies. Their relevance for the differentiation of autoimmune diseases].
Blaschek MA
Wien Med Wochenschr; 1987 Jul; 137(13):295-301. PubMed ID: 3307167
[TBL] [Abstract][Full Text] [Related]
2. [Non-organ specific anticytoplasmic autoantibodies. Immunoserologic detection and diagnostic relevance].
Blaschek MA
Wien Med Wochenschr; 1987 Jul; 137(13):303-9. PubMed ID: 3307168
[TBL] [Abstract][Full Text] [Related]
3. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
4. [Autoantibodies].
Ishihara Y
Rinsho Byori; 2005 Jun; 53(6):562-9. PubMed ID: 16026086
[TBL] [Abstract][Full Text] [Related]
5. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
8. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
[TBL] [Abstract][Full Text] [Related]
9. [Optimizing the clinical value of polyreactive autoantibodies to double-stranded DNA].
Haberhauer G; Chlud K; Isovits D
Z Gesamte Inn Med; 1989 Nov; 44(21):652-4. PubMed ID: 2692314
[TBL] [Abstract][Full Text] [Related]
10. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
11. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
14. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
15. [Assessment methods of autoantibodies in autoimmune diseases].
Zabek J
Przegl Epidemiol; 2002; 56 Suppl 4():59-66. PubMed ID: 14750264
[TBL] [Abstract][Full Text] [Related]
16. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
18. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
19. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
[TBL] [Abstract][Full Text] [Related]
20. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
